DateEvents
October 2021The patient was diagnosed with mixed connective tissue disease (MCTD) and treated with non-steroidal anti-inflammatory drugs and sulfasalazine for arthritis
18 DecemberOnset of fever, chills, sore throat, and cough
19 DecemberSudden onset of chest pain
20 DecemberPresented to a local hospital with prolonged symptoms
Echocardiogram revealed a mildly decreased left ventricular ejection fraction (LVEF; 50%) and small pericardial effusion Admitted to a local hospital with a diagnosis of acute myocarditis
21 DecemberLVEF decreased drastically to 20%. Computed tomography revealed mild pulmonary oedema, systemic lymphadenopathy, and hepatosplenomegaly. Cardiac T2-weighted magnetic resonance imaging revealed a slightly high signal intensity in the mid-to-apical myocardium
22 DecemberReferred to our institution.
Blood tests revealed elevated troponin-I, creatinine kinase, and C-reactive protein levels. Coronary angiography revealed no significant stenosis, while right ventricular endomyocardial biopsy revealed mild inflammatory cell infiltration in the cardiac muscle and an absence of eosinophils, giant cells, and granulomas; these were consistent with myocarditis. However, fulminant myocarditis did not seem likely
24 DecemberSteroid pulse therapy (1000 mg/day) was initiated because of prolonged fever, chest pain, tachycardia, and new onset of myalgia
25–27 DecemberLVEF did not improve, and mitral regurgitation became severe. The dobutamine dosage was increased, and diuretics were administered
27 DecemberSudden cardiac arrest occurred after crying due to emotional distress Venoarterial extracorporeal membrane oxygenation (VA-ECMO) and intra-aortic balloon pumping (IABP) were initiated
28 DecemberPrednisolone sodium succinate was initiated (100 mg/day)
29 DecemberIntravenous cyclophosphamide (IVCY) was initiated (1000 mg)
30 DecemberLVEF suddenly improved to 40%
31 DecemberLVEF improved to 50–55%. Successful weaning off of VA-ECMO
1 January 2022Withdrawal of IABP
3 JanuarySuccessfully extubated without neurological damage
5–27 JanuaryOral prednisolone dosage was reduced from 60 to 25 mg per week
27 JanuarySecond course of IVCY (500 mg) was initiated
3 FebruaryShe was discharged with full walking ability
DateEvents
October 2021The patient was diagnosed with mixed connective tissue disease (MCTD) and treated with non-steroidal anti-inflammatory drugs and sulfasalazine for arthritis
18 DecemberOnset of fever, chills, sore throat, and cough
19 DecemberSudden onset of chest pain
20 DecemberPresented to a local hospital with prolonged symptoms
Echocardiogram revealed a mildly decreased left ventricular ejection fraction (LVEF; 50%) and small pericardial effusion Admitted to a local hospital with a diagnosis of acute myocarditis
21 DecemberLVEF decreased drastically to 20%. Computed tomography revealed mild pulmonary oedema, systemic lymphadenopathy, and hepatosplenomegaly. Cardiac T2-weighted magnetic resonance imaging revealed a slightly high signal intensity in the mid-to-apical myocardium
22 DecemberReferred to our institution.
Blood tests revealed elevated troponin-I, creatinine kinase, and C-reactive protein levels. Coronary angiography revealed no significant stenosis, while right ventricular endomyocardial biopsy revealed mild inflammatory cell infiltration in the cardiac muscle and an absence of eosinophils, giant cells, and granulomas; these were consistent with myocarditis. However, fulminant myocarditis did not seem likely
24 DecemberSteroid pulse therapy (1000 mg/day) was initiated because of prolonged fever, chest pain, tachycardia, and new onset of myalgia
25–27 DecemberLVEF did not improve, and mitral regurgitation became severe. The dobutamine dosage was increased, and diuretics were administered
27 DecemberSudden cardiac arrest occurred after crying due to emotional distress Venoarterial extracorporeal membrane oxygenation (VA-ECMO) and intra-aortic balloon pumping (IABP) were initiated
28 DecemberPrednisolone sodium succinate was initiated (100 mg/day)
29 DecemberIntravenous cyclophosphamide (IVCY) was initiated (1000 mg)
30 DecemberLVEF suddenly improved to 40%
31 DecemberLVEF improved to 50–55%. Successful weaning off of VA-ECMO
1 January 2022Withdrawal of IABP
3 JanuarySuccessfully extubated without neurological damage
5–27 JanuaryOral prednisolone dosage was reduced from 60 to 25 mg per week
27 JanuarySecond course of IVCY (500 mg) was initiated
3 FebruaryShe was discharged with full walking ability
DateEvents
October 2021The patient was diagnosed with mixed connective tissue disease (MCTD) and treated with non-steroidal anti-inflammatory drugs and sulfasalazine for arthritis
18 DecemberOnset of fever, chills, sore throat, and cough
19 DecemberSudden onset of chest pain
20 DecemberPresented to a local hospital with prolonged symptoms
Echocardiogram revealed a mildly decreased left ventricular ejection fraction (LVEF; 50%) and small pericardial effusion Admitted to a local hospital with a diagnosis of acute myocarditis
21 DecemberLVEF decreased drastically to 20%. Computed tomography revealed mild pulmonary oedema, systemic lymphadenopathy, and hepatosplenomegaly. Cardiac T2-weighted magnetic resonance imaging revealed a slightly high signal intensity in the mid-to-apical myocardium
22 DecemberReferred to our institution.
Blood tests revealed elevated troponin-I, creatinine kinase, and C-reactive protein levels. Coronary angiography revealed no significant stenosis, while right ventricular endomyocardial biopsy revealed mild inflammatory cell infiltration in the cardiac muscle and an absence of eosinophils, giant cells, and granulomas; these were consistent with myocarditis. However, fulminant myocarditis did not seem likely
24 DecemberSteroid pulse therapy (1000 mg/day) was initiated because of prolonged fever, chest pain, tachycardia, and new onset of myalgia
25–27 DecemberLVEF did not improve, and mitral regurgitation became severe. The dobutamine dosage was increased, and diuretics were administered
27 DecemberSudden cardiac arrest occurred after crying due to emotional distress Venoarterial extracorporeal membrane oxygenation (VA-ECMO) and intra-aortic balloon pumping (IABP) were initiated
28 DecemberPrednisolone sodium succinate was initiated (100 mg/day)
29 DecemberIntravenous cyclophosphamide (IVCY) was initiated (1000 mg)
30 DecemberLVEF suddenly improved to 40%
31 DecemberLVEF improved to 50–55%. Successful weaning off of VA-ECMO
1 January 2022Withdrawal of IABP
3 JanuarySuccessfully extubated without neurological damage
5–27 JanuaryOral prednisolone dosage was reduced from 60 to 25 mg per week
27 JanuarySecond course of IVCY (500 mg) was initiated
3 FebruaryShe was discharged with full walking ability
DateEvents
October 2021The patient was diagnosed with mixed connective tissue disease (MCTD) and treated with non-steroidal anti-inflammatory drugs and sulfasalazine for arthritis
18 DecemberOnset of fever, chills, sore throat, and cough
19 DecemberSudden onset of chest pain
20 DecemberPresented to a local hospital with prolonged symptoms
Echocardiogram revealed a mildly decreased left ventricular ejection fraction (LVEF; 50%) and small pericardial effusion Admitted to a local hospital with a diagnosis of acute myocarditis
21 DecemberLVEF decreased drastically to 20%. Computed tomography revealed mild pulmonary oedema, systemic lymphadenopathy, and hepatosplenomegaly. Cardiac T2-weighted magnetic resonance imaging revealed a slightly high signal intensity in the mid-to-apical myocardium
22 DecemberReferred to our institution.
Blood tests revealed elevated troponin-I, creatinine kinase, and C-reactive protein levels. Coronary angiography revealed no significant stenosis, while right ventricular endomyocardial biopsy revealed mild inflammatory cell infiltration in the cardiac muscle and an absence of eosinophils, giant cells, and granulomas; these were consistent with myocarditis. However, fulminant myocarditis did not seem likely
24 DecemberSteroid pulse therapy (1000 mg/day) was initiated because of prolonged fever, chest pain, tachycardia, and new onset of myalgia
25–27 DecemberLVEF did not improve, and mitral regurgitation became severe. The dobutamine dosage was increased, and diuretics were administered
27 DecemberSudden cardiac arrest occurred after crying due to emotional distress Venoarterial extracorporeal membrane oxygenation (VA-ECMO) and intra-aortic balloon pumping (IABP) were initiated
28 DecemberPrednisolone sodium succinate was initiated (100 mg/day)
29 DecemberIntravenous cyclophosphamide (IVCY) was initiated (1000 mg)
30 DecemberLVEF suddenly improved to 40%
31 DecemberLVEF improved to 50–55%. Successful weaning off of VA-ECMO
1 January 2022Withdrawal of IABP
3 JanuarySuccessfully extubated without neurological damage
5–27 JanuaryOral prednisolone dosage was reduced from 60 to 25 mg per week
27 JanuarySecond course of IVCY (500 mg) was initiated
3 FebruaryShe was discharged with full walking ability
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close